baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Esperite NV/ NL0009272137 /

10/28/2022 5:35:02 PM	Chg. -	Volume	Bid3:00:48 AM	Ask3:00:48 AM	High	Low
0.0092EUR	-	1.97 mill. Turnover: 18,928.8390	-Bid Size: -	-Ask Size: -	0.0102	0.0090

GlobeNewswire 10/10/2019 Worldwide DNA Read, Write & Edit Markets to 2024 | Technologies, Applications, Innovations, Patents,...

GlobeNewswire 7/19/2019 Whole Genome and Exome Sequencing Markets, 2019-2023 by Research, Clinical, Direct to Consumer, Agri...

GlobeNewswire 5/28/2019 DNA Sequencing Research, Applied and Clinical Markets, 2023

GlobeNewswire 1/10/2019 ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investm...

GlobeNewswire 11/30/2018 ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 23rd tranche of investm...

GlobeNewswire 11/29/2018 Esperite (ESP) with The Cell Factory, prepares to raise series A round of investments to continue it...

GlobeNewswire 11/27/2018 ESPERITE N.V. convenes Annual General Meeting of Shareholders

GlobeNewswire 11/23/2018 ESPERITE (ESP): financial results for 2017 are published.

GlobeNewswire 11/19/2018 ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018

GlobeNewswire 11/9/2018 ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018

GlobeNewswire 11/8/2018 Whole Genome and Exome Sequencing: Worldwide Market Opportunities (2018-2022) Featuring 40+ Key Play...

GlobeNewswire 11/7/2018 Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biolog...

GlobeNewswire 11/6/2018 Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-in...

GlobeNewswire 10/15/2018 ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investm...

GlobeNewswire 10/3/2018 Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled

GlobeNewswire 9/13/2018 ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CR...

GlobeNewswire 8/31/2018 Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.

GlobeNewswire 8/29/2018 ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investm...

GlobeNewswire 8/15/2018 Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017.

GlobeNewswire 7/18/2018 Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017

GlobeNewswire 7/9/2018 Global Strategic Business Outlook on the Genetic Testing Market 2016-2018 to 2024: Ballooning Global...

GlobeNewswire 7/2/2018 ESPERITE N.V. (ESP) SELLS ITS STAKE IN CRYOSAVE SOUTH AFRICA TO GO LIFE HEALTHCARE (GLI).

GlobeNewswire 6/28/2018 ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 20th tranche of investm...

GlobeNewswire 6/26/2018 Global Whole Genome and Exome Sequencing Markets 2018-2022 & 2023: Diagnostic Factors, Interpreting ...

GlobeNewswire 6/19/2018 Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity a...

Esperite NV/ NL0009272137 /

If you wish to receive reply to your feedback, please provide your email address.